Veronese, N.
Stubbs, B.
Koyanagi, A.
Hébert, J. R.
Cooper, C.
Caruso, M. G.
Guglielmi, G.
Reginster, J. Y.
Rizzoli, R.
Maggi, S.
Shivappa, N.
Funding for this research was provided by:
National Institutes of Health
Merck Research Laboratories
Novartis Pharmaceuticals Corporation
GlaxoSmithKline
Pfizer
Article History
Received: 23 August 2017
Accepted: 27 September 2017
First Online: 10 October 2017
Compliance with ethical standards
:
: Dr. JRH owns controlling interest in Connecting Health Innovations LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DII) from the University of South Carolina to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Dr. NS is an employee of CHI. Prof. Reginster received consulting fees or paid advisory boards from IBSA-GENEVRIER, MYLAN, Radius Health, PIERRE FABRE; lecture fees when speaking at the invitation of sponsor: IBSA-GENEVRIER, MYLAN, CNIEL, Dairy Research Council (DRC), and grant supports from IBSA-GENEVRIER, MYLAN, CNIEL, Radius Health.